# Giorgio Parmiani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giorgio-parmiani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,911 |
| Field | Immunotherapy and Immune Responses |
| h-index | 87 |
| i10-index | 323 |
| Last Known Institution | Molecular Oncology (United States) |
| OpenAlex ID | https://openalex.org/A5062210857 |
| ORCID iD | https://orcid.org/0000-0002-2929-0254 |
| Works | 625 |

## Researcher papers

- [Defining the critical hurdles in cancer immunotherapy](https://scholariq.org/papers/defining-the-critical-hurdles-in-cancer-immunotherapy/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

## Researcher university

- [Molecular Oncology (United States)](https://scholariq.org/institutions/molecular-oncology-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.